Should You Cycle TRT With Clomiphene? (TRT Q&As)
Timeline
Cycling between testosterone and Clomiphene may work initially, but Dr. O’Connor questions whether the approach will remain effective or sustainable over time. He says many men eventually choose stable low-dose TRT, while fertility concerns can be addressed separately when necessary.
There is no established ideal ratio for combining these drugs. Dr. O’Connor emphasizes minimizing overall exposure and says men who add Masteron or Primobolan to testosterone should consider the potential effects on hair, acne, sexual function, and long-term health.
Loss of libido after multiple anabolic steroids can represent significant disruption of the hormonal system, with recovery potentially taking a long time. Dr. O’Connor considers the situation too complex to solve from limited information and recommends a comprehensive medical evaluation, especially if depression becomes severe.
A sudden PSA increase of this magnitude should be repeated promptly rather than automatically blamed on Primobolan. At age 30, Dr. O’Connor considers prostatitis, infection, or prostate trauma more likely explanations and recommends urology evaluation if the PSA remains elevated.
Video Summary
This mailbag discussion focuses on questions about libido changes reported during testosterone therapy. It explains that sexual desire is influenced by hormonal, psychological, relational, and health factors rather than testosterone alone. Libido variability is framed as multifactorial rather than a direct dose-response effect.
A central portion examines why libido may improve initially and later fluctuate or plateau. The episode discusses expectation effects, stress, sleep, and relationship context as contributors to perceived change. Contextual evaluation is emphasized to avoid unnecessary protocol escalation.
The closing segment integrates sexual function expectations into long-term testosterone management. Ongoing reassessment, expectation alignment, and proportional decision-making are highlighted. Hormone therapy is positioned as supportive rather than determinative of sexual experience.
Drug Callouts
Condition Callouts
Key Takeaways
- Libido changes during testosterone therapy are multifactorial.
- Sexual desire is not strictly dose-dependent.
- Psychological and relational factors influence libido.
- Avoiding escalation prevents unnecessary risk.
- Expectation alignment improves long-term satisfaction.